미국의 독립계 진단 검사 시설 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 부문별 예측(2026-2033년)

U.S. Independent Diagnostic Testing Facility Market Summary

The U.S. independent diagnostic testing facility market size was estimated at USD 10.08 billion in 2025 and is projected to reach USD 18.09 billion by 2033, growing at a CAGR of 7.66% from 2026 to 2033. The growth is driven by the growing burden of chronic and lifestyle-related diseases, rising preference for cost-efficient, accessible, and faster diagnostics, and increasing technological advancements, including digital imaging, AI-enabled diagnostics, portable diagnostics, and improved telehealth integration.

In addition, value-based healthcare initiatives and supportive reimbursement structures for certain diagnostic procedures are encouraging providers to shift services to independent diagnostic testing facilities.

U.S. Independent Diagnostic Testing Facility Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. independent diagnostic testing facility market report based on service:

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Radiology/Imaging Services
  • X-Ray
  • Computed Tomography (CT)
  • Magnetic Resonance Angiography (MRA)
  • Magnetic Resonance Imaging (MRI)
  • Mammography
  • Ultrasound
  • Positron Emission Tomography (PET) Scan
• Sleep Studies
• Cardiac Monitoring Services

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. U.S. Independent Diagnostic Testing Facility Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Service segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
  • 3.2.1. Market Dynamics
    • 3.2.1.1. Market Driver Analysis
    • 3.2.1.2. Market Restraint Analysis
    • 3.2.1.3. Market Opportunities Analysis
    • 3.2.1.4. Market Challenges Analysis
• 3.3. Regulatory Framework
• 3.4. Business Environment Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis

Chapter 4. Service Business Analysis

• 4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
• 4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
• 4.3. Service Movement & Market Share Analysis, 2025 & 2033
• 4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
• 4.5. Radiology/Imaging Services
  • 4.5.1. Radiology/imaging services market, 2021 - 2033 (USD Million)
  • 4.5.2. X-Ray
    • 4.5.2.1. X-ray market, 2021 - 2033 (USD Million)
  • 4.5.3. Computed Tomography (CT)
    • 4.5.3.1. Computed tomography (CT) market, 2021 - 2033 (USD Million)
  • 4.5.4. Magnetic Resonance Angiography (MRA)
    • 4.5.4.1. Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
  • 4.5.5. Magnetic Resonance Imaging (MRI)
    • 4.5.5.1. Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
  • 4.5.6. Mammography
    • 4.5.6.1. Mammography market, 2021 - 2033 (USD Million)
  • 4.5.7. Ultrasound
    • 4.5.7.1. Ultrasound market, 2021 - 2033 (USD Million)
  • 4.5.8. Position Emission Tomography (PET) Scan
    • 4.5.8.1. Position emission tomography (PET) scan market, 2021 - 2033 (USD Million)
• 4.6. Sleep Studies
  • 4.6.1. Sleep studies market, 2021 - 2033 (USD Million)
• 4.7. Cardiac Monitoring Services
  • 4.7.1. Cardiac monitoring services market, 2021 - 2033 (USD Million)

Chapter 5. Company Landscape

• 5.1. Company Categorization
• 5.2. Company Market Position Analysis, 2025
• 5.3. Strategy Mapping
• 5.4. Company Profiles/Listing
  • 5.4.1. RadNet, Inc.
    • 5.4.1.1. Overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Service benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. Vitalistics
    • 5.4.2.1. Overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Service benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. Breathe
    • 5.4.3.1. Overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Service benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Texas MRI
    • 5.4.4.1. Overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Service benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. The Brookwood Diagnostic Center
    • 5.4.5.1. Overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Service benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. ACS Diagnostics, Inc.
    • 5.4.6.1. Overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Service benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. Houston MRI & Diagnostic Imaging
    • 5.4.7.1. Overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Service benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. TestSmarter Inc.
    • 5.4.8.1. Overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Service benchmarking
    • 5.4.8.4. Strategic initiatives
  • 5.4.9. Duke University and Duke University Health System
    • 5.4.9.1. Overview
    • 5.4.9.2. Financial performance
    • 5.4.9.3. Service benchmarking
    • 5.4.9.4. Strategic initiatives
  • 5.4.10. Covenant Health Diagnostics
    • 5.4.10.1. Overview
    • 5.4.10.2. Financial performance
    • 5.4.10.3. Service benchmarking
    • 5.4.10.4. Strategic initiatives
  • 5.4.11. AliveCor, Inc.
    • 5.4.11.1. Overview
    • 5.4.11.2. Financial performance
    • 5.4.11.3. Service benchmarking
    • 5.4.11.4. Strategic initiatives
  • 5.4.12. Advanced Cardio Services
    • 5.4.12.1. Overview
    • 5.4.12.2. Financial performance
    • 5.4.12.3. Service benchmarking
    • 5.4.12.4. Strategic initiatives
  • 5.4.13. Diagnostic Medical Testing Inc.
    • 5.4.13.1. Overview
    • 5.4.13.2. Financial performance
    • 5.4.13.3. Service benchmarking
    • 5.4.13.4. Strategic initiatives
  • 5.4.14. K & T Diagnostic, Inc.
    • 5.4.14.1. Overview
    • 5.4.14.2. Financial performance
    • 5.4.14.3. Service benchmarking
    • 5.4.14.4. Strategic initiatives
  • 5.4.15. Vestavia Diagnostic Center (VDC)
    • 5.4.15.1. Overview
    • 5.4.15.2. Financial performance
    • 5.4.15.3. Service benchmarking
    • 5.4.15.4. Strategic initiatives
  • 5.4.16. Advanced Imaging Center
    • 5.4.16.1. Overview
    • 5.4.16.2. Financial performance
    • 5.4.16.3. Service benchmarking
    • 5.4.16.4. Strategic initiatives